Skip to main content
Top
Published in: Diabetologia 8/2016

Open Access 01-08-2016 | Commentary

Basal insulin delivery reduction for exercise in type 1 diabetes: finding the sweet spot

Authors: Hood Thabit, Lalantha Leelarathna

Published in: Diabetologia | Issue 8/2016

Login to get access

Abstract

Exercise poses significant challenges to glucose management in type 1 diabetes. In spite of careful planning and manipulation of subcutaneous insulin administration, increased risk of hypoglycaemia and glycaemic variability during and after exercise may occur as a result of inherent delays in insulin action and impaired counter-regulatory hormone responses. Various strategies to mitigate this issue have been advocated in clinical practice, including ingestion of supplementary carbohydrate prior to exercise, reducing background and pre-meal insulin bolus and performing bouts of resistance/high intensity exercise before aerobic exercise. Insulin pump therapy, considered the most physiological form of insulin replacement for type 1 diabetes allows modulation of basal insulin delivery before, during and after exercise. However uncertainty remains regarding the optimal strategy to reduce basal insulin delivery and its efficacy. In this issue of Diabetologia, McAuley and colleagues (DOI: 10.​1007/​s00125-016-3981-9) report on the impact of a 50% reduction of basal insulin delivery before, during and after moderate-intensity aerobic exercise. Results from this study may contribute to a better understanding of the effects of basal insulin delivery manipulation and may aid in devising therapeutic approaches for glucose management during exercise.
Literature
1.
go back to reference Pozzilli P, Battelino T, Danne T, Hovorka R, Jarosz-Chobot P, Renard E (2016) Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics. Diabetes Metab Res Rev 32:21–39CrossRefPubMed Pozzilli P, Battelino T, Danne T, Hovorka R, Jarosz-Chobot P, Renard E (2016) Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics. Diabetes Metab Res Rev 32:21–39CrossRefPubMed
2.
go back to reference Chimen M, Kennedy A, Nirantharakumar K, Pang TT, Andrews R, Narendran P (2012) What are the health benefits of physical activity in type 1 diabetes mellitus? A literature review. Diabetologia 55:542–551 Chimen M, Kennedy A, Nirantharakumar K, Pang TT, Andrews R, Narendran P (2012) What are the health benefits of physical activity in type 1 diabetes mellitus? A literature review. Diabetologia 55:542–551
4.
go back to reference Thorell A, Hirshman MF, Nygren J et al (1999) Exercise and insulin cause GLUT-4 translocation in human skeletal muscle. Am J Physiol 277:E733–E741PubMed Thorell A, Hirshman MF, Nygren J et al (1999) Exercise and insulin cause GLUT-4 translocation in human skeletal muscle. Am J Physiol 277:E733–E741PubMed
6.
go back to reference Franc S, Daoudi A, Pochat A et al (2015) Insulin-based strategies to prevent hypoglycaemia during and after exercise in adult patients with type 1 diabetes on pump therapy: the DIABRASPORT randomized study. Diabetes Obes Metab 17:1150–1157CrossRefPubMed Franc S, Daoudi A, Pochat A et al (2015) Insulin-based strategies to prevent hypoglycaemia during and after exercise in adult patients with type 1 diabetes on pump therapy: the DIABRASPORT randomized study. Diabetes Obes Metab 17:1150–1157CrossRefPubMed
7.
go back to reference Rönnemaa T, Koivisto VA (1988) Combined effect of exercise and ambient temperature on insulin absorption and postprandial glycemia in type I patients. Diabetes Care 11:769–773CrossRefPubMed Rönnemaa T, Koivisto VA (1988) Combined effect of exercise and ambient temperature on insulin absorption and postprandial glycemia in type I patients. Diabetes Care 11:769–773CrossRefPubMed
8.
go back to reference Mitchell TH, Abraham G, Schiffrin A, Leiter LA, Marliss EB (1988) Hyperglycemia after intense exercise in IDDM subjects during continuous subcutaneous insulin infusion. Diabetes Care 11:311–317CrossRefPubMed Mitchell TH, Abraham G, Schiffrin A, Leiter LA, Marliss EB (1988) Hyperglycemia after intense exercise in IDDM subjects during continuous subcutaneous insulin infusion. Diabetes Care 11:311–317CrossRefPubMed
9.
go back to reference Bally L, Zueger T, Buehler T et al (2016) Metabolic and hormonal response to intermittent high-intensity and continuous moderate intensity exercise in individuals with type 1 diabetes: a randomised crossover study. Diabetologia 59:776–784CrossRefPubMed Bally L, Zueger T, Buehler T et al (2016) Metabolic and hormonal response to intermittent high-intensity and continuous moderate intensity exercise in individuals with type 1 diabetes: a randomised crossover study. Diabetologia 59:776–784CrossRefPubMed
10.
go back to reference Bergenstal RM, Klonoff DC, Garg SK et al (2013) Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med 369:224–232CrossRefPubMed Bergenstal RM, Klonoff DC, Garg SK et al (2013) Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med 369:224–232CrossRefPubMed
11.
go back to reference Zaharieva DP, Miadovnik LA, Rowan CP, Gumieniak RJ, Jamnik VK, Riddell MC (2016) Effects of acute caffeine supplementation on reducing exercise-associated hypoglycaemia in individuals with Type 1 diabetes mellitus. Diabet Med 33:488–496CrossRefPubMed Zaharieva DP, Miadovnik LA, Rowan CP, Gumieniak RJ, Jamnik VK, Riddell MC (2016) Effects of acute caffeine supplementation on reducing exercise-associated hypoglycaemia in individuals with Type 1 diabetes mellitus. Diabet Med 33:488–496CrossRefPubMed
Metadata
Title
Basal insulin delivery reduction for exercise in type 1 diabetes: finding the sweet spot
Authors
Hood Thabit
Lalantha Leelarathna
Publication date
01-08-2016
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 8/2016
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-016-4010-8

Other articles of this Issue 8/2016

Diabetologia 8/2016 Go to the issue

Up front

Up Front

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.